Vitamin D3 Nanoemulsion Shows Promise for Autism Symptoms

Publication date: Jul 04, 2025

The nanoemulsion delivered vitamin D3 more effectively than conventional supplements, leading to measurable improvements in autism severity scores, social skills, and language development over six months of treatment. While both groups experienced increases in blood vitamin D3 levels, only children receiving the nanoemulsion showed meaningful behavioral improvements, suggesting that enhanced bioavailability may be crucial for therapeutic benefits. This nanotechnology approach addresses known absorption challenges with vitamin D3, particularly important for children with autism who often have gastrointestinal issues that can impair nutrient uptake. One group received the vitamin D3 nanoemulsion while the other received a standard marketed vitamin D3 product. The vitamin influences several brain systems relevant to autism, including serotonin pathways, dopamine concentrations, and the balance between excitatory and inhibitory neurotransmitters. Enhanced Absorption Technology The research team developed a nanoemulsion containing vitamin D3 in droplets just 61 nanometers in size-roughly 1,000 times smaller than the width of human hair. The nanoemulsion formulation encapsulated more than 98% of vitamin D3 efficiently, using safe ingredients including olive oil, glycerol, and natural flavoring.

Semantics

Original Article